ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000691.1|Acarbose_1 # 1 # 201 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000691.1|Acarbose_1 	1	201	+	Loose	550	21.557	APH(2'')-Ig	40.0	3002669	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	CTCACAGCGGGGCGCTCTCAGCGGGAGCGCACCGAGTCCGACATGCGCCAGCGTGCCGTGGACGCCGCCGGCTGGGCCGACCTGGTCGGCTCCGGCCGGATCACCGACGCCGCGACGCTCGCGGCCTACACCCTGCTGCGGATGTACGACAGCGGAACGCGACAGCCCATGCCGGAAGGAGCCGAATCGTGCACGTGGTGA	LTAGRSQRERTESDMRQRAVDAAGWADLVGSGRITDAATLAAYTLLRMYDSGTRQPMPEGAESCTW	MCEFSSPQIPITDIENAMERIGSPVRELRRLDAGDDSEVLLCNGLFVIKIPKRPSVRVTQQREFAVYSFLKQYDLPALIPEVIFQCSEFNVMSFIPGENFGFQEYALLSEKEKEALASDMAIFLRRLHGISVPLSEKPFCEIFEDKRKRYLEDQEQLLEVLENRKLLNAPLQKNIQTIYEHIGQNQELFNYAACLVHNDFSSSNMVFRHNRLYGVIDFGDVIVGDPDNDFLCLLDCSMDDFGKDFGRKVLRHYGHRNPQLAERKAEINDAYWPIQQVLLGVQREDRSLFCKGYRELLAIDPDAFIL	21.57	gnl|BL_ORD_ID|831|hsp_num:0	903			162	222	amikacin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0000691.1|Acarbose_2 # 189 # 2393 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=AAGG;rbs_spacer=9bp;gc_cont=0.734	BGC0000691.1|Acarbose_2 	189	2393	+	Loose	850	29.261	OprJ	31.17	3000802	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCACGTGGTGAGCTTCGCCTTCGAAGCCCTCGCCTTCGACGTAGGGATGATGCGCGGCGGGCTCGCCCCGCTGGCCTGGGAACTGGCCCGCCACTACGCCGCCCAGGGACACCGCTCCTCGATCGTCACCCCGGCGCACGGCCGCCTGCCGTACCTCGCCGAGCGGTACGACCTGGTCGAACTCGACTACCGGGACGAGCATGTCGTTCCCGTGGTCCCGGACCCCGACGTCTGGGCGGGGCAGCCCCGCGAACTGGGCCTGCCCCTGGTCACCCGGGCCCACCTGCTGCGGCACGAGGGCGTCGACATCTACCTGCTCAGCGACGAGTACCTCGATCTGCTGCCGGAGCGGCTCTACCCGGCCGGCACGAGTGAGGGCAGCGACCTGGCGTACTTCAAACCGCTGGTGTTCCAGGTCGGTGGGCTGCGCTTCCTGCAGTCCCGGCTGGCCGGTGACGAGCCCGCCGTCGTGCAGGCCTACGAGCCGTACTACCACTACCTCCTGCCCCCGGTGCTGGCCGGCGACCCGCGGTTCCGGGTGATGTCCACGGTGGCCAGCAGCATGCCGATCGACCTGGGTGTGTACCGGCCCCAGGTGGACCGCCTGCTCGAGCACTTCGGCGCCGGCACCGACCTGGACCGCTATGTGGAGAGCCCGGTCGCGGCCGGCGCCGACCATCCCGCGGCCACCCGCGAGGCGGCGCTGGGCGCGGCGATGGCCGGATACCTGCCGACGACCCGGCTCTCCAGCGGGCGGCGGCGGGCCGACTACGTGGGCCTGTTCGCGCTGATCACCGACCACTGCGACACGGTGGACTTCCTGACCCCGGGGCAGCGGCGGTTCTACTCGACGTTCCGGGACACCCCGTACGAGGCGGCGTTCCGGCGGACCGCGGTGGCCCGGGTGGTCCGGGAGAACGCGGCGAAACAGTTCGTCGGCGGCTGTGCGCTGCCGGAGAACTGGCTGCGGCGGGACCCGGCCGAGGTGGACCGGGCGGCGTACCTCTCCGGGCTCGGGCTGGACCCGGCGCTGCCGACCTTCTACCACGTGGGCCGGTACTCGCCGCACCACAAGGGTCAGGTGGAGCTCTTCCGGGCGGTCGAGCGGATCCTCGCCACCGACACCCGGGTCAACTTCGTGCTGCGCTGCGCCACCTCGGCCGGCGGCGGCGGCGCCAGGATCGGTGACCCCGCCTTCCAGGCGGTGGCCGACCGGCACCCCGGCCAGGTGCGGCTCTTCTGGACCATGGCCGACGAGGACGAACTGTTCACCGAGGCGGTGGCGGCGGACTTCGGGTTGTTCCCGTCCAAGTACGAACTGGACACCTTCCTGACCGCCCAGGGGCAGCTGTGCGCCTGCGGCGCGGTGCCGATCGGGACCGCGCAGGAGTCGACCCGGCACTACCGGCACCAGCTGGCCACCGACCATCCGCTGGCCACCGGATTCGCCCTGCCGCGCTCCTTCACCCCGGACGACGAACGTCTGACCGGCGCTCTGGTGCGTACCATGCGGGAGGCGCTGCGGATGTACCGCGACGAACCGGGCGAGTACCGGCGGCTGGCCGGCAACGCCGCCGAACTCGCCCGCACCTTCCGCTACGCCGAGGTGTCCCGGCGACGGCTCGCCCACTTCGCGAAGCTGCTCGACGGCACGCCGACAGCGGCCGACCCGGAGCACGTCATCGGGTGCGGCTGGTTCGACCAGTTGGACGCCGCGCAGTGGGCGGCCCACCTGCCGCAGATCCGGCGCGAAGCGATCCGCCTCGGTGACCTGGAGACGCTGCGCCGCTGCGGCCCGGTCGACCCGGGCGCGCTCGGCGCACTGTACGAGGCCGCGTACCGGCGTGCCGACTTCGACCGGTGCGTGCGGGTCGCGGAACTGCTGGGCGACCGGGGCAGCGAGGCGGTGTCGCTGCGCCGGCGCTGCCGGGTACGGCCGCACGAGCAGGGCTGGGAGATCCAGTACCGGGCGCCGGGCGCCGAGCAGGTGGCCCTGGTGGTCGGCGGTACCGCCCACCGGATGCACGGTTCGGCCGGCCGGTTCAGCACGGTGCTGCCCACGGTGCCGATGCCGTCACCGGTGTTCCTGCTGACGCTGGCCTCCGGACGGTACGCGTGGGACGCCCCACCGGCCACCGCACACCTCGCCGACCTCGCCGGTCAGCCGCACCCGGCGCAGCCGGTCGGGGCCGGGGGCCGCTGA	MHVVSFAFEALAFDVGMMRGGLAPLAWELARHYAAQGHRSSIVTPAHGRLPYLAERYDLVELDYRDEHVVPVVPDPDVWAGQPRELGLPLVTRAHLLRHEGVDIYLLSDEYLDLLPERLYPAGTSEGSDLAYFKPLVFQVGGLRFLQSRLAGDEPAVVQAYEPYYHYLLPPVLAGDPRFRVMSTVASSMPIDLGVYRPQVDRLLEHFGAGTDLDRYVESPVAAGADHPAATREAALGAAMAGYLPTTRLSSGRRRADYVGLFALITDHCDTVDFLTPGQRRFYSTFRDTPYEAAFRRTAVARVVRENAAKQFVGGCALPENWLRRDPAEVDRAAYLSGLGLDPALPTFYHVGRYSPHHKGQVELFRAVERILATDTRVNFVLRCATSAGGGGARIGDPAFQAVADRHPGQVRLFWTMADEDELFTEAVAADFGLFPSKYELDTFLTAQGQLCACGAVPIGTAQESTRHYRHQLATDHPLATGFALPRSFTPDDERLTGALVRTMREALRMYRDEPGEYRRLAGNAAELARTFRYAEVSRRRLAHFAKLLDGTPTAADPEHVIGCGWFDQLDAAQWAAHLPQIRREAIRLGDLETLRRCGPVDPGALGALYEAAYRRADFDRCVRVAELLGDRGSEAVSLRRRCRVRPHEQGWEIQYRAPGAEQVALVVGGTAHRMHGSAGRFSTVLPTVPMPSPVFLLTLASGRYAWDAPPATAHLADLAGQPHPAQPVGAGGR	MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVDAELRRLVDMALDNIRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAGNRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYLSYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQKQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRLRARNADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSCSFLPTLTLPIFDGGRNRANLSLAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYESGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS	153.24	gnl|BL_ORD_ID|745|hsp_num:0	704			807	1038	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000691.1|Acarbose_3 # 2395 # 3246 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGC;rbs_spacer=14bp;gc_cont=0.734	BGC0000691.1|Acarbose_3 	2395	3246	+	Loose	700	27.7202	mdtG	48.78	3001329	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGACGGCATCGGCACCACACCCCCGCGCGACCACCGGGTCGTCGCGACCGACCTCGACGGCACCCTGCTGCGCTCCGACCTGACCGTGTCCGCCCGGACCCGCGCGGCGCTGCGCGACGCCCGGGCGGCCGGCATGATCCACCTCGCGGTGACCGGCCGCCCGGTGATCGACACCCGCCGGCTGCTCGCCGGGCTGGGCTACACCGGCCCGGCGGTCTGCGGTCAGGGCGCCCAGGTGTACGACTTCGGCACCGACCGGCTGCTGCTGAGCCGCAGCCTCGACACCGACCTGGTGCGCGAGCTGGTGCGCCGGATCGCGCAGCGGACCGGTCCGCTCGCGCTGGCCGCGGTGAGCGCCGGCCTGGGCACCGAGTTCCTGGTCACCGCCGGTTTCGGTGCCCCCTACCAGCAGCATCGCTGGCAGCTCGTCGACGAGCCGGACCTGTGGCGTGCGCCGGTCGCCAAGGTGCTGATCCGGCACCCGGACCACGACGACGACACGCTCGCGGCACTCGCCGACGAGGTCTGCGGCGCGGCGCTGTCGGTGATGCACGCCGGTCCGGGCCTGGTCGAACTGCTGCCCGGTGACACCAGCAAACGCACCGGCCTGGCCTTTCTCGCCGCCGAACTGGGCTTCACCGGGGCCGACACCATCGCCTTCGGGGACATGCCCAACGACCTGCCGATGTTCGACTGGGCCGGGTACGGCGTCGCGATGGCTAACGGCCACCCCCGGCTGCGCGACCGCGCCGACGAGATCACTGTCAGCAACGACGCGGACGGCGTGGCCGTGGTGCTCGAACGTCTGCCCGCCGTCCGGGCCGGAAACCGAAAGGCAAGCCTGCGATGA	MDGIGTTPPRDHRVVATDLDGTLLRSDLTVSARTRAALRDARAAGMIHLAVTGRPVIDTRRLLAGLGYTGPAVCGQGAQVYDFGTDRLLLSRSLDTDLVRELVRRIAQRTGPLALAAVSAGLGTEFLVTAGFGAPYQQHRWQLVDEPDLWRAPVAKVLIRHPDHDDDTLAALADEVCGAALSVMHAGPGLVELLPGDTSKRTGLAFLAAELGFTGADTIAFGDMPNDLPMFDWAGYGVAMANGHPRLRDRADEITVSNDADGVAVVLERLPAVRAGNRKASLR	MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN	69.36	gnl|BL_ORD_ID|550|hsp_num:0	603			1065	1188	fosfomycin
BGC0000691.1|Acarbose_4 # 3243 # 5339 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=10bp;gc_cont=0.748	BGC0000691.1|Acarbose_4 	3243	5339	+	Loose	550	28.4906	vgbC	23.73	3003990	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin B antibiotic	antibiotic inactivation	streptogramin vgb lyase	ATGACCACCACGACGGATGCCGCGCTGATCGAGCTGGCCGGACGGTACGGGGTGTCGGTCGACTGGACCACCGACCGCGGCGAGCCGCGGACGGTGCCGGCCGACACGATCCAGCGGATCCTGGCTGTGCTCGGTGTGGACGCGAGCTCCGGCCCCGCGATCGCCGCCGCGCTGCGTGCCGCGGACGACGACGCCCGGCACCGGCTGCTGCCGTCCTGCGTGGTGGTGCGGCAGGGGGAACCGGCCAGGGGAGTCCACCCGGTGGCCGGGGCCGCCTATGTGGTGGCGACCGAGGACGGTGGCCGGCACGAGACGGCCGACCCGCGCAACGACCTCGGCCGCCTTCCGATCGGATACCACACGCTGCGCGTACGGGTGGGCGACCGGTCCGCCGCCGCGCCGGTGATCGTGGCTCCGGCCGTCCTCGGCACCCCGGACCGGCGGCACTGGGGGATGCTGGCGCAGATCTACTCCGTACTGTCCGAACGGTCCTGGGGGATGGGCGACCTCGGCGACCTGGCCGACCTGACCCGCTGGTCGGCCCGGCTCGGGGCGTCGTTCGTGCTGGTCAATCCGATGCACGCCTACGTGCCGGACCGCCTGGCCGACCCCACGCCCTACCGGCCGGGCAGCCGGCGGTTCGCCGACCCGATGTATCTGCGGCTGGCCGACGTCGCCGAGTACGCGACCGCGGAACCGGCGGTGCGGGCCGAACTCGACCGGGCCGCCCGTCAGGGACACGAACTGACCGCCGAGGTGCTGCACCGGAACGCGCTGATCGACCGGGCTCGGGTGTGGCCGGTCAAGCGGAACGCCCTGGAGCGGCTCTACCGGGCACCCCGCACGGCCGGGCGGTCCGCGGCTCTGGCCGCCTTCACCGCCCGCGAGGGCCGGGGTCTCGAGGACTACGCCACCTGGTGTGCGCTGGCCGAGGTGTACGGCACCCGCTGGCGTTCCTGGCCGGCCGCTCTGCAATCCCCGCACGGCCCGGCGGTCGCCGCCGCCCGCCGCGAGCTGGTCGACCGGATCGATTTCCACCGCTGGCTGGCCTGGCTCGTCGACGAGCAGATGGCCGCGGCCCAGGCGGCCGCCGTCGGGTCCGGCATGGCGATCGGCGTGATCCACGACTTGGCCGTCGGCGTCGACCCGGAGGGTGCCGACGCGTGGGCGGTGCAGGATCATCTGGCCGGCGGTGTCACGGTGGGCTGCCCGGCCGACGACTTCAACCCGCTCGGGCAGGACTGGGGGTTGCCGCCGTGGCGCCCGGACACCCTGGCCGAAGCCGGTTACCGGCCGTTCGCCGACGTGATCCGCGGCACCCTGCGGCACAGCGGGGCGCTGCGGCTGGACCACATTCTCGGCCTGTTCCGGCTCTGGTGGATCCCGGCCGGGAGCGGCGCCCGCGACGGTGCCTACGTCCGCTACGACCACGAGGCCATGCTCGGGGTGCTGGCCGTCGAGGCGTTCCGGGCCGGGGCGATGATCATCGGCGAGGATCTGGGCACCGTCCATCCGGCGGTCCGTGCCGAACTCGCCGACCGGGGCATCCTCGGCACGTCCGTGCTGCGCTTCGAGTACCAGGGCGGATCGGAGAACCGCAGCGGGCCGCTGCCGGCCGACCAGTGGCGTGCCGGCTGCCTGGCCACCCTCACCACCCACGACCTGCCGAGTACGGCCGCCTGGCTCAGCGGTGAGCACGTGGACCTGCAGGACCGGCTGGGCCTGCTGAACCGGCCCCGAGCCGAGGTGGCCGCCGACGCGGCGGCCGAACGTGACGGCTGGCTGGCCGAGTTGCGGCGCACCGGTCTGCTGGAGCACGAGACCGCCGTACCGGGGATGAGCGCCGAGTCGCTGGCCCTGCACCGGTTCCTGGCCCGGACCCCGGCCCGCCTGGTCGGAGTGTGGCTGCCCGACCTGGTCGGCGACCGGAGGCCGCAGAACCTGCCGGGCACCAGCACCGAGTTCCCGAACTGGCAGCTGCCGGTCGCCGACGCCGACGGCCGGCCGGTGGCGATGGACGACCTGGCGTCCTCGGCCGGCGCCCAAGCGGTCGCCGGCCTGTACGCCGCATCGGCCGAGCCGGCCACCACACCCTGA	MTTTTDAALIELAGRYGVSVDWTTDRGEPRTVPADTIQRILAVLGVDASSGPAIAAALRAADDDARHRLLPSCVVVRQGEPARGVHPVAGAAYVVATEDGGRHETADPRNDLGRLPIGYHTLRVRVGDRSAAAPVIVAPAVLGTPDRRHWGMLAQIYSVLSERSWGMGDLGDLADLTRWSARLGASFVLVNPMHAYVPDRLADPTPYRPGSRRFADPMYLRLADVAEYATAEPAVRAELDRAARQGHELTAEVLHRNALIDRARVWPVKRNALERLYRAPRTAGRSAALAAFTAREGRGLEDYATWCALAEVYGTRWRSWPAALQSPHGPAVAAARRELVDRIDFHRWLAWLVDEQMAAAQAAAVGSGMAIGVIHDLAVGVDPEGADAWAVQDHLAGGVTVGCPADDFNPLGQDWGLPPWRPDTLAEAGYRPFADVIRGTLRHSGALRLDHILGLFRLWWIPAGSGARDGAYVRYDHEAMLGVLAVEAFRAGAMIIGEDLGTVHPAVRAELADRGILGTSVLRFEYQGGSENRSGPLPADQWRAGCLATLTTHDLPSTAAWLSGEHVDLQDRLGLLNRPRAEVAADAAAERDGWLAELRRTGLLEHETAVPGMSAESLALHRFLARTPARLVGVWLPDLVGDRRPQNLPGTSTEFPNWQLPVADADGRPVAMDDLASSAGAQAVAGLYAASAEPATTP	MQIAAQEYKTANRESGPYGITARQDRTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVMSILSAHTGDLWFTEYKANKIGRMTMEGTFAEFELPEANSSPYGLAEGPDGAIWFTELSGNRIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPTEQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAITAGVSGDLWFTEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY	235.81	gnl|BL_ORD_ID|2244|hsp_num:0	2526			369	534	pristinamycin IA; quinupristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3
BGC0000691.1|Acarbose_5 # 5371 # 6270 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=6bp;gc_cont=0.741	BGC0000691.1|Acarbose_5 	5371	6270	+	Loose	275	28.1054	vanE	22.35	3002907	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGTCGGAGCACACCGACGTCCTCGTCCTCGGCGGCGCCGGCGTCGACACCATCGCCTACGTGCCCGAACTGCCGCTGCCGTTCCAGGACAGCTACGTGGTCGCGGCCATCGAACCACGAGCCGGGCAGACCGGCGACAACGTCGCTCTCGGCCTGCACACGCTGGGCCTGCGCACGATGCACGTCGACGTGCTCGGCGACGACCCGGAAGGTGACCTGGTCCGGGCCTTCCACACCCGGCACGGTCTGCCGTTCGCCGCCCTGCCCACGGCCGCCGGCACCAAGCGGGCGGTGAACCTGGTCGGCCCGGACGGCCGCCGGCTGTCGCTGTGGGACGGCAGCCGGGAAGCCGAGGAGGACCGCTACCCGGCCGCCCTGATCGCCGCGCACACCGCCCACGCCCGGCACGTGCACGTCTGCATCACCCCGCCCGGGCAGCACGTGTTCGGCCAGCTCAACGACCTGCCGGTCACCGTCTCCACCGACCTGCACAATTGGGACGGCGCCTACGAGGGCTTCGAGGTCTACGCCTTCAACGCCGACCTGGTGTTCCTGTCGGCGACCGCGCTGACCGACGTGGCCGCGACGATGCGCCGCGTCATCGACCGGGGCCGGGCCCGGCTGGTGGTGGCCACCGACGGCGCCCACGGCGGATCGGTGCTGGTGCGCGGCGAGACGGAGGTCCGGCGGTACGCGGCGGTGGCCCCCGAGGCGCCGGTGGTGGACTCCAACGGCGCCGGTGACGCGTTCGTGTCCGGCTTCCTCTTCGGGCACCTGGCCGGCGAACCGCTGGAGACCTGCCTGCGCTACGGCGCGATCGCCGGCGCCTACGCGTGCACCATCCCCGCCACCCGGGCCGGCGCCATCGACCGGGCCGCGCTGCTGCGGCCGGCGGCGTGA	MSEHTDVLVLGGAGVDTIAYVPELPLPFQDSYVVAAIEPRAGQTGDNVALGLHTLGLRTMHVDVLGDDPEGDLVRAFHTRHGLPFAALPTAAGTKRAVNLVGPDGRRLSLWDGSREAEEDRYPAALIAAHTAHARHVHVCITPPGQHVFGQLNDLPVTVSTDLHNWDGAYEGFEVYAFNADLVFLSATALTDVAATMRRVIDRGRARLVVATDGAHGGSVLVRGETEVRRYAAVAPEAPVVDSNGAGDAFVSGFLFGHLAGEPLETCLRYGAIAGAYACTIPATRAGAIDRAALLRPAA	MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKDRWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYVGCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEAGSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISLVDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGEILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID	84.94	gnl|BL_ORD_ID|1478|hsp_num:0	1617			483	723	vancomycin
BGC0000691.1|Acarbose_6 # 6297 # 7346 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.759	BGC0000691.1|Acarbose_6 	6297	7346	+	Loose	2000	26.5646	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	40.48	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGGCCGACGTGGGCGGCACCCACCTGCGCTGGGCACGGTGGTCACCGGACGGCGGACTGGGCGAAGTGCACACCACGCCGTCTCCGGGGCACGCCCGGCGGCCCGGCGCCGGTGCCGCCGACCTGCAGGCGGAACTGATCCGCGAGCTGGCGTCGCGGGTCGAGCCGGGTGCGCGGGCCGGTGTCTCGCTCGGCGCGGCCATGGACCACCACAGTGGTACGGCGTACGCCTCCGCGCCGTTGTGGGGTCCGCAGGTCAGCCCGTTCGACGTGCCGGCCGCCCTGCGCGCCGCCCGGCCGGACGTGCACTGGACCGTGGTCAACGACGTCACGGCGGGGCTGCTGCACCTGGCCGAGATGGTTCGCGACGCCGGCGTCCGCAAGGCGTGCCTGGTCACGATCAGCACCGGCATCGCCTGCCGGACGATGGACCTGCGCACCGGCGGTATCCCGGTCGACGCGGCCGGCCTCCAGGGCGAGATCGGTCACCTGCCGGCGACCGTGCTGGCCGACGGGGTGCCGGTGGTGACCCGCTGCGACTGCGGTGAGCCGGGGCACGTGGCGGCGTCCTCGTCCGGGCCGGGCATTCGACGGGTCGCGGCCGTCCTGGCCCGGCGTGACCCGGCCACCTGGGCGGGCTCCGGGCCGACCACCCGGATGATGGCGGGCTCGGGCTTCGAGGACGCGTTCCGGGCCGCTCTGGACGACGGCGATCCGGTCGCGGCGGACCTGCTGACGGCGGTGACCGCCCCGATCGCGGACCTGCTGCGGACCGCCCTCTGCCTGGACCCGGAACTCGACCTGATCGCGCTGACCGGTGGAGTCGCCCACGGGCTGGAACCGCACTACTCGGCGGCGGTGCACGACCACCTGCGGCGCCGGGGGCTCTACCTGACCTCCGAGCGGGAGCCGGACTGGTTGACCGGGCGGATCCGGGTCGTCCCGCCGGCGACGGCCGATCCGTTGGTCGGCGCCGGTCTGGCCGCACTGGCGGCGGGGCCGGTCCCGGCGTACTCCGGTGGTGGCCGGGAAGCGTTGGTCGGGCGATGA	MADVGGTHLRWARWSPDGGLGEVHTTPSPGHARRPGAGAADLQAELIRELASRVEPGARAGVSLGAAMDHHSGTAYASAPLWGPQVSPFDVPAALRAARPDVHWTVVNDVTAGLLHLAEMVRDAGVRKACLVTISTGIACRTMDLRTGGIPVDAAGLQGEIGHLPATVLADGVPVVTRCDCGEPGHVAASSSGPGIRRVAAVLARRDPATWAGSGPTTRMMAGSGFEDAFRAALDDGDPVAADLLTAVTAPIADLLRTALCLDPELDLIALTGGVAHGLEPHYSAAVHDHLRRRGLYLTSEREPDWLTGRIRVVPPATADPLVGAGLAALAAGPVPAYSGGGREALVGR	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	29.43	gnl|BL_ORD_ID|4719|hsp_num:0	2914			1848	1968	rifampin
BGC0000691.1|Acarbose_7 # 7343 # 8443 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AAG;rbs_spacer=13bp;gc_cont=0.747	BGC0000691.1|Acarbose_7 	7343	8443	+	Loose	660	33.8834	MexS	33.77	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCCGGCACCGCGCGATCGTGCGCACCGGCACCGGCGTGGTGGTCGCCGACGTCCCGACCCCGGTGCCGGGGCCGGGAGAGCTGTTGGTCGGCACCGAGTGGGCGGGACTGTGCGGCACCGACATCCAGATGCTGCGCGGCCTGCGCGACGATCCCGAACCGATCATCGGCCACGAGGGGATCGCCCGGGTGATCGCGGCCGGCGACGGCGTGCCCGGCACGCTGCGGCCGGGGACCCTGGTGGCGGTCAACCCGACCCACCGGGACGATCCGTCGTTCCTGCTCGGGCACAACGTTCCCGGCCTGCTGCAGGAACGGACGCTGCTGCCGGCCACCGCGGTCTCCGGTGGCTTGGTGCTCCCGCTGCCGGACGGCACCGACGTCACGCTGGGCCCGCTGCTGGAACCGCTGGCCGTGGTCAGCTATGCGCTGAGCCAGCTCGGCGCCGTCCGCCCGGCCACCCTGGTGATCGTCGGCGACGGAACGGTGGGTCACCTGGCCGCCCGGGCTGCGGTGACCTGGCTGGCGGAGCGGCCCCGGGTGGTGCTGGTGCACCACACGGCAGCGGGGCGGGACTTCAGCGCGGCCGGGCCGCATCCGGCGGACGTTCTGCTCACCACCGGCGAGCTGGCGGGCAGACCGCTGCCGGGACCGGTGGCCGCCCTGCTGGCGACCCCACGGGACGCGACTGTCGAGGCCCTGGAGGCGGTCCTGGCCGCGGCCGGCGCCGATGTGCTGATCGACGTGCTGGGCGGCCTGCCCCCGGGCGCGCGATCGGCGATGCTGCCCGGTGTCGATCTCACCGCCGTGCGGGCGGCCAACTGCGGCGGCTTCCCGGAACCGGCTCTGGTCACCACCACCTCCGGCGGAACCCGGCTCTTCGGGCATCGCGGGGTGGGCAACGCGCACCTGCGGGCGGCGGCCGGCGAGCTGGCCCGCGACCCGGACCGGTACCGGGATCTCGTCACCCATCGCAGCGATCTGGCCGGCGCGGCCCGGATCATGACCGCGCTCCGGAGCGGCCGGGACCGGATCATCGACGGCCGCCGACTGGTGAAGCTCGCGATCCAGGTCAATGTCAGAGAGGATCATCGATGA	MSRHRAIVRTGTGVVVADVPTPVPGPGELLVGTEWAGLCGTDIQMLRGLRDDPEPIIGHEGIARVIAAGDGVPGTLRPGTLVAVNPTHRDDPSFLLGHNVPGLLQERTLLPATAVSGGLVLPLPDGTDVTLGPLLEPLAVVSYALSQLGAVRPATLVIVGDGTVGHLAARAAVTWLAERPRVVLVHHTAAGRDFSAAGPHPADVLLTTGELAGRPLPGPVAALLATPRDATVEALEAVLAAAGADVLIDVLGGLPPGARSAMLPGVDLTAVRAANCGGFPEPALVTTTSGGTRLFGHRGVGNAHLRAAAGELARDPDRYRDLVTHRSDLAGAARIMTALRSGRDRIIDGRRLVKLAIQVNVREDHR	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	107.96	gnl|BL_ORD_ID|1039|hsp_num:0	1041			57	285	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000691.1|Acarbose_8 # 8440 # 9195 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.749	BGC0000691.1|Acarbose_8 	8440	9195	+	Loose	340	24.6386	sta	58.33	3004699	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGAGCGGGACTCTGGTGGGCCGCCGCGCCCTGGTGGTGGGCGGAACCACGGGCATCGGCCGGGGCATCGCCGACGCGTGGGCCGCGGCCGGCGCCGAGGTGACCGTCTGTGGCCGCAGCGAGCCGGCCGGCGATGGCGCCGCCGGGTTGCACTGGGAGCCGCTCGACCTGACCCGGACCGGGGAGGCCGGTGCGCGCCTGGAACGGATCGCCGGTGACCGGGTCGATCTGGCCTGCTTCGCCGCGGTCTCCTACGGGGCCCGGCGCGCCGTCTTCGAGGACGTGGCGGTGGACGAATGGCGTACCCAGCTGGACATCAACGTGCACGGCCTGTGGCTCACCCTGCGGGCGGCACTGCCGGGGCTGCGTGCCGCCCGGCCCGGCCTGTTCGTGGGCGTCTCGTCCGAGGTGGTCTACAACGCCGGGCCCGGCCGCTCCGGGTACACCGCCTCCAAGGCGGCCGCGAAGGCGCTGCTGGAGTCGGTGGCCCAGGAGGAGGACGAGAGCCGGGTCCGGATCGTGCAGGTGCTGCCGGCCGGGATGGTCGATACTCCGAGCATCCGGCGCCGTCGCCCGGCCGGCTTCGACTACAGCGACTACATGGTGCCCGCCGATTTCGCGCGCAACGCGCTGGAACTCGCCGCCACGGCCGGCGCCGGCCACCACGGGGACAGCCTGGTGGTCGACAGGGGCGGCGACTGGTGGTCGGTGCGCGAGCGGATGCCGGTGTCGCAGAGCCGGCCGGTGCGGACGTGA	MSGTLVGRRALVVGGTTGIGRGIADAWAAAGAEVTVCGRSEPAGDGAAGLHWEPLDLTRTGEAGARLERIAGDRVDLACFAAVSYGARRAVFEDVAVDEWRTQLDINVHGLWLTLRAALPGLRAARPGLFVGVSSEVVYNAGPGRSGYTASKAAAKALLESVAQEEDESRVRIVQVLPAGMVDTPSIRRRRPAGFDYSDYMVPADFARNALELAATAGAGHHGDSLVVDRGGDWWSVRERMPVSQSRPVRT	MTTTHGSTYEFRSARPGDAEAIEGLDGSFTTSTVFEVDVTGDGFALREVPADPPLVKVFPDDGGSDGEDGAEGEDADSRTFVAVGADGDLAGFAAVSYSAWNQRLTIEDIEVAPGHRGKGIGRVLMRHAADFARERGAGHLWLEVTNVNAPAIHAYRRMGFAFCGLDSALYQGTASEGEHALYMSMPCP	132.80	gnl|BL_ORD_ID|2220|hsp_num:0	3397			264	336	streptothricin
BGC0000691.1|Acarbose_10 # 10001 # 11155 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AAGG;rbs_spacer=9bp;gc_cont=0.700	BGC0000691.1|Acarbose_10 	10001	11155	+	Loose	850	25.7942	OpmH	34.43	3003682	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGTGGTGTCGAGACGGTAGGGGTGCACGCGGATGCGCACCGCGACTCGTGGCAGGTGCGGGCCCAGAAGCAGATCACCTACGAGGTGCGCTTCCGGGACGACGTGTTCGGGCTGGACTCCACCGACCTGCTGGAGGCCGGGGCGGACGGGGCCGGTTCACGGCGGCGGTTCGTGGTGGTGGACAGCGCCGTCGACGCCTTGTACGGGTCCCGGATCCGGGAGTACTTCACCCATCACGGCATCGATCATTCGATCCTGGTGATGCGGGTGGGCGAGACGGTCAAGGACTTCGACACGGCGGGCCGCATCGTCGCCGCGATGGACGCCTTCGGACTGGCCCGCCGCCGGGAGCCGATGATCGTCGTCGGTGGTGGGGTGCTGATGGACGTGGCCGGTCTGGTGGCCAGCCTCTACCGGCGCGGCACGCCGTTCCTGCGGGTGCCGACGACACTGGTCGGACTGATCGACGCGGGTGTCGGCGCGAAGACCGGGGTCAACTTCAACGGCCACAAGAACCGGCTGGGTACGTACGCCCCGGCTGATCTGACCCTGCTGGACCGCCGCTTCCTGGCCACCCTGGACCGGCGCCACCTCAGCAACGGGCTCGCCGAGATGCTCAAGATCGCGCTGATCAAGGATGCCGAGCTGTTCCAGCTGCTGGAGCGGCACGGGCGGGTCCTGATCGAGGAACGGTTCCAGGGCCGTACCGGAACCGGTGACCGGGCCGCCGTCCGGGCCCTGCGCGCGGCCACCCATGGCATGCTGGAGGAACTCGGCCCCAATCTGTGGGAGAGCCGGCTGGAACGCAGTGTCGACTACGGGCACACGTTCAGCCCGACCATCGAGATGCGCGCGCTGCCGGCTCTGCTGCACGGCGAGGCCGTGTGTGTGGACATGGCGCTGACCACGGTGCTGGCGTACCGGCGGGGTCTGCTCGACGTCGCGCAGCGGGACCGGATCTTCGCGGTGATGACCGCCCTGGGCCTGCCGACCTGGCATCCGCTGCTCACGCCGGAGGTGCTGGAGGCGGCGTTGCAGGACACCGTCCGGCACCGGGACGGGTGGCAGCGGCTGCCACTGCCGGTGGGGATCGGGGGTGTCACGTTCGTCAACGACGTGACGGCCGGCCGAGCTGCAGGCCGCCCGCGCTGA	MSGVETVGVHADAHRDSWQVRAQKQITYEVRFRDDVFGLDSTDLLEAGADGAGSRRRFVVVDSAVDALYGSRIREYFTHHGIDHSILVMRVGETVKDFDTAGRIVAAMDAFGLARRREPMIVVGGGVLMDVAGLVASLYRRGTPFLRVPTTLVGLIDAGVGAKTGVNFNGHKNRLGTYAPADLTLLDRRFLATLDRRHLSNGLAEMLKIALIKDAELFQLLERHGRVLIEERFQGRTGTGDRAAVRALRAATHGMLEELGPNLWESRLERSVDYGHTFSPTIEMRALPALLHGEAVCVDMALTTVLAYRRGLLDVAQRDRIFAVMTALGLPTWHPLLTPEVLEAALQDTVRHRDGWQRLPLPVGIGGVTFVNDVTAGRAAGRPR	MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY	79.67	gnl|BL_ORD_ID|2005|hsp_num:0	2195			519	702	triclosan
BGC0000691.1|Acarbose_11 # 11261 # 12223 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.643	BGC0000691.1|Acarbose_11 	11261	12223	-	Loose	1200	35.039	arnA	23.65	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAAATCTTGGTCACCGGCGGAGCCGGCTTTATCGGGTCCCATTTTGTAACTTCCCTGATCAGTGGCGACATTGCCACACCACAACCCGTGACGCAGGTTACGGTCGTCGACAAACTGGGTTACGGAGGCAATCTCAGAAATCTCGCCGAAGCGTCGGCGGACCCTCGTTTCAGCTTCGTTCGGGGCGACATCTGTGACGAAGGTCTAATCGAGGGGCTGATGGCGCGGCACGACACCGTGGCGCACTTCGCCGCCGAGACCCACGTCGACCGCTCGGTGGTCGCCTCCGGCCCCTTCGTGGCCAGCAACCTGGTCGGCACTCAGGTGCTACTGGACGCCGCGCTACGCCACCATATCGGCCGCTTCCTGCATGTTTCCACCGACGAGGTGTACGGGTCGATCGACACCGGCTCGTGGGCCGAGGGCCATCCGCTGGCGCCCAACTCGCCGTACGCCGCGAGCAAAGCCGGGTCCGACCTCCTCGCTCTGGCCTACCACCAGACGCACGGGATGGACGTCGTGGTGACCCGCTGCTCGAACAACTACGGGCCCCGGCAATTCCCGGAGAAAATGATTCCGCTGTTCGTCACCAGGCTGCTCGACGGGCTCGACGTACCGGTCTACGGCGACGGCCGCAACATCCGCGACTGGCTCCACGTCAGCGACCATTGCCGCGGTCTCGCCCTGGCCCTGGGTGCCGGCCGGGCAGGCGAGGTCTATCACATCGGCGGTGGGTGGGAGGCGACGAATCTCGAATTGACCGAGATCCTCCTCGAGGCGTGCGGCGCCCCGGCTTCGCGCATATCTTTCGTGACCGATCGCAAAGGTCACGACCGGCGCTATTCTCTCGACTATTCGAAAATCGCCGGGGAACTCGGTTACCGGCCGCGGGTCGATTTCACCGACGGCATCGCGGAAACGGTCGCGTGGTATCGCGCCAACCGTTCCTGGTGGACCTGA	MKILVTGGAGFIGSHFVTSLISGDIATPQPVTQVTVVDKLGYGGNLRNLAEASADPRFSFVRGDICDEGLIEGLMARHDTVAHFAAETHVDRSVVASGPFVASNLVGTQVLLDAALRHHIGRFLHVSTDEVYGSIDTGSWAEGHPLAPNSPYAASKAGSDLLALAYHQTHGMDVVVTRCSNNYGPRQFPEKMIPLFVTRLLDGLDVPVYGDGRNIRDWLHVSDHCRGLALALGAGRAGEVYHIGGGWEATNLELTEILLEACGAPASRISFVTDRKGHDRRYSLDYSKIAGELGYRPRVDFTDGIAETVAWYRANRSWWT	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	48.34	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1785	polymyxin B
BGC0000691.1|Acarbose_12 # 12354 # 13217 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGC;rbs_spacer=15bp;gc_cont=0.706	BGC0000691.1|Acarbose_12 	12354	13217	+	Loose	200	25.0238	FosX	37.14	3000198	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	GTGACCTGGGCGGTTTCCAAACAACTGATGCCGGTCTATGACAAACCGATGATCTACTATCCGCTGGCCACGCTCGTCAGCTGCGGGATCCGGGAGATCCTGGTCATCACGACCGAGACCGAGGCCGCCCAGTTCCAGCGGTTGCTGGGTGACGGCTCGCAGTGGGGCCTGCGTCTGGAGTTCGCCGTGCAGCAGCGCCCCGGGGGCATCGCCGAGGCCTTCCTCATCGGCGAGGAGTTCCTGGCCGGTGGGCCGGTGGCGCTCATGCTCGGCGACAACCTGCTGCACGGGGTGGACTTCCGCCCCTGCGTGCAGCGGGCACGCGAGACGGCCGGTGGGCACGTCTTCGGAGTGGCGGTGGCCGACCCGTCGGCCTACGGGGTGGTCGAGTTCGACGCCGCCGGGCGGGTGCTGTCCATCGAGGAGAAACCGGTCCGTCCCCGCTCGCCGTACGCGGTTCCCGGCTTCTACCTCTACGACGCCGATGTGGTCGAGACGGCCCGGTCGCTGCGGCCCAGCGCCCGCGGGGAGCTGGAGATCACCGAGGTCAACCAGGCCTACCTGCGGCGCGGCGCACTCTCGGTGACGCTGCTGGGTCGGGGCGCGGTCTGGCTCGACACCGGCACCCTGGCCGACTGCATGCGCGCGGTCGACTACGTGCGCGCCATCGACGAGGGCCAGGGCATCAAGATCGGCTGTGTGGAGGAGGCGGCCTGGCGGGCCGGTTTCCTCGACACCGCGCAGCTGCGTGCCCTCGCCGAGCCGTTGATGAGCAGCGGCTACGGACAGTACCTGCTGGCTCTGACCGGCGACGGGCTCAGCCGTACCCCGCAGTGGCCGGCCTTGACCGCCGCCGCCGGGTGA	MTWAVSKQLMPVYDKPMIYYPLATLVSCGIREILVITTETEAAQFQRLLGDGSQWGLRLEFAVQQRPGGIAEAFLIGEEFLAGGPVALMLGDNLLHGVDFRPCVQRARETAGGHVFGVAVADPSAYGVVEFDAAGRVLSIEEKPVRPRSPYAVPGFYLYDADVVETARSLRPSARGELEITEVNQAYLRRGALSVTLLGRGAVWLDTGTLADCMRAVDYVRAIDEGQGIKIGCVEEAAWRAGFLDTAQLRALAEPLMSSGYGQYLLALTGDGLSRTPQWPALTAAAG	MISGLSHITLIVKDLNKTTAFLQNIFNAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGDSLQERTYNHIAFQIQSEEVDEYTERIKALGVEMKPERPRVQGEGRSIYFYDFDNHLFELHAGTLEERLKRYHE	215.79	gnl|BL_ORD_ID|111|hsp_num:0	129			234	339	fosfomycin
BGC0000691.1|Acarbose_13 # 13310 # 16426 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.709	BGC0000691.1|Acarbose_13 	13310	16426	-	Loose	400	30.4166	JOHN-1	35.29	3000840	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	JOHN beta-lactamase	ATGGATGAAAGACTGAAATCTCATATCGTCCGGGCGCTGCTGCCCGTGCTGGTGGGGGCCGCCGGTGGCCTGCCGGCTCCGCGGGCCGCGCAGGCCGAATCGCCGCCGGACCGGCCGTCCCACGCCGAGCAGCTCTACCTGGTGATGCCCGACCGGTTCGCCAACGGCGACACCGGCAACGATCAGGGCGGGCTGACCGGAGACCGGCTCACCACCGGGTACGACCCCACCGACGCCGGCTTCTACCACGGCGGCGACATCCAGGGCGTGATCGACAAACTGGACTACATCCAGGGGCTCGGTACCACGGCGATCTGGCTGACGCCGATCTTCAAGAACAAGCCGGTGCAGGGTACGGGTCCGAACGCGTCCGCCGGCTACCACGGCTACTGGATCACCGACTTCACCCAGGTCGACCCGCACTTCGGGACCAACGAGGACCTCAAGCGGCTGGTCGGCCTCGCCCACCGGCGCGGCATGAAGATCTACCTCGACATCGTGGTGAACCACACCGCCGACGTGATCAAGAACGCCGAGGGCACCGCCTACGCCGACAAGGGAACCGCGCCCTACCGCGACACCGCGGGTCGTCCCTTCGAGGACCGCAACTACGCCGACGGGACACACGGCTTCCCCAAGGTCGACGAGAAGTCGTTCCCCCACCGGCCGTTCTTCGAGAAGCCGTCCGACGCCACCGCCAAGGCACCCGCCTGGCTCAACGACCCGACCATGTACCACAACCGGGGCGAGACCACCTTCGGCGGGGAGAACGCCGAATACGGCGACTTCACCGGCGGCCTCGACGATCTGTGGACCGAGCGGCCCGAGGTGCTGCACGGGCTGACCGACATCTACGCCGGCTGGATCCGGCGGTTCGGCGTCGACGGCTACCGGCTGGACACCCTCAAAGCCACCGACCTGGCGTTCTGGCGGCCTTTCGCCGAGGGCGTGGGCAAGGCCGCGGACAAGGCGGGCAAGCGTGACTTCTTCCTCTTCGGTGAGGCCTGGAGCAAGGACCAGGAAGTCACCTCGACGTTCGTCCGCCGGGGCGGCCTGCCCGCGACCCTCGACTTCCCGTTCCAGGGCGCGGCCCAGAGCTACGCGCGCGGGCAAGGCACCGGCCAGCAGCCTTGGCAGGACCTGTACGCGAAGGACGACCTCTACAGCCGCCGGCCGGGACCGACGCCGGCCGGCTGCCACCTCGGCGAGTGGAACCACGACATGGGCCGGATCGCCACTCTGATCAAGGCCGGCTCCGATCCGAAACGCGGGTGCCGGCTCGAACTGGTGAACGAGCTGATGTTCCTCACCCGCGGCCAGCCGGGTGGTCTACTCCGGGCCGACGAGCAGGGCTTCACCGGGCGCCCTCGGCTGAACAAGGGCTCGCGCCAGGACATGTTCGCCAGCCGGACACCGGACTACCTGGACGACCGCCTGATCGGCACCGACAAGACCCACGCGAGCGACAACCACGACACCGGGCACCCGCTCTACCGCACCATCGCCGAGCTGGGCGCCGTGCGCAAGGCCCACCCGGGACTGCGTGACGGTGAGCAGATCACCCGGTACGCCGCCGACCGCGCCGGGGTCTTCGCCGCCTCCCGCATCGACCGCGACCAGCGTGCCGAGTATGTGATCGCGGTGAACAACGCGACCACCGCGCAGACCGTCACCTTCGACACCTACACCCCGGGCTGCGGCTTCCAGCCTCTCTACGGCACCGGCGAGACGGCGGCCACCGGTGCCGACGGCCGGCTCACCATCACCGTGCCGGCGCTGTCGGCGGTGGCCTATCGGGCCGAGAAACCGATCCCCGCGGCGGACGGCGCCCCCGCCGTGACGATCACCGCACCCGCGGGCCGGGACCCTCGTGCCGGGCCGCACCGAACTGACCGCGCCGTCACCGGCGACCCGCTGTCCACCGTCACCTTCTCCGCCCGCGCCGGTAACGGGCCGTGGCAGCCGATCGGCACGGCCGGACGGGGCCCGTACCGGGTGTTCCACGACCTGACCGGACTGGCCGGCGGCGCCGAGGTGCAGTACCGGCGGTCGCCCGGGACGCCGAGGCCGTACCGCCACCACCACCAGCCGGATCCGGTCGGCACCGTGCGGGCCGAGGCGGGCTACGCCGTCGTGCACTATCAGCGTCCCGCCGGCGACTACGACGGCTGGCGCCTGCACGCCACCGGCGAACGTTCGAAGCGGCCGCGCTCGAACCCGCAGGGAGAGCCGTTCACCGGGAACGGAACGCCTAACGGGCCGTTCGCCTGGGTCAAACTGCGGCCCGGCGCCACGAAGGTCACCTTCACCGTGAGTGACGCCAACGGTGTCAAGGACGTCGACGCCGACCGCTCGCTCAATCCCCAGCAGACACCCGGGATCTGGCTGCACCAGGGCGACCCGGCCATCTCCTACCAGGGTCCGGCGCCCGCACCCGCGCCGAACACCGCGATCCTGCACTACCGGCGTCCAGCCGGCGATTACACCGGCTGGGGCCTGCACCTGTGGGACGGTGCGGCCACCCCCACCGCCGACTGGGGCGCGCCGCTGCTGCCGGAGTCGTTCGACAGCTTCGGTGCGGTCTTCCGGATCCCGCTGGCGGCCGGGGCCACCGGTCTCAGCTACATCATGCACGCCGGCGAGGCCAAGGATCTGCCGACCGACCAGCGGCTGGAGTTCGCCGACGCGGGCCGGGAGGTCTGGGTGCAGGCGGGCGTCCAGGAACGGCTGCTGCCGTCGGTGGTGAAACCGGCGAAACTCGATCTGACCAGGGCCGACGCGGTGCGGGTGGACCGGGACACGATCGCCTGGCAGACCGGTACGCCCGACACGCTGGAACCGGCCGGGGCAGCCACCGACGGGCGCGTCTACGACCTCGTGCACGCCCCGAACGGTGGGCTGCGCCTGGTCGACGGTGACCTCGCCGGCGACTATCGCAGCATCCGGCTGACCGCGCAGCGCGACGGCCTCACCGAGAAGCAGCGGCGGCAGGCACCGGAACTGTGGCAGTACCCGGCGTTCCAGGCGGCGGCCGCCCTGCCCTCCGGTGACGGACAGTTCTATGTGACTGAGCGGGATGCGCAAGGCCGGCTCATGTCGGTGACCGGAGTCCGCTGA	MDERLKSHIVRALLPVLVGAAGGLPAPRAAQAESPPDRPSHAEQLYLVMPDRFANGDTGNDQGGLTGDRLTTGYDPTDAGFYHGGDIQGVIDKLDYIQGLGTTAIWLTPIFKNKPVQGTGPNASAGYHGYWITDFTQVDPHFGTNEDLKRLVGLAHRRGMKIYLDIVVNHTADVIKNAEGTAYADKGTAPYRDTAGRPFEDRNYADGTHGFPKVDEKSFPHRPFFEKPSDATAKAPAWLNDPTMYHNRGETTFGGENAEYGDFTGGLDDLWTERPEVLHGLTDIYAGWIRRFGVDGYRLDTLKATDLAFWRPFAEGVGKAADKAGKRDFFLFGEAWSKDQEVTSTFVRRGGLPATLDFPFQGAAQSYARGQGTGQQPWQDLYAKDDLYSRRPGPTPAGCHLGEWNHDMGRIATLIKAGSDPKRGCRLELVNELMFLTRGQPGGLLRADEQGFTGRPRLNKGSRQDMFASRTPDYLDDRLIGTDKTHASDNHDTGHPLYRTIAELGAVRKAHPGLRDGEQITRYAADRAGVFAASRIDRDQRAEYVIAVNNATTAQTVTFDTYTPGCGFQPLYGTGETAATGADGRLTITVPALSAVAYRAEKPIPAADGAPAVTITAPAGRDPRAGPHRTDRAVTGDPLSTVTFSARAGNGPWQPIGTAGRGPYRVFHDLTGLAGGAEVQYRRSPGTPRPYRHHHQPDPVGTVRAEAGYAVVHYQRPAGDYDGWRLHATGERSKRPRSNPQGEPFTGNGTPNGPFAWVKLRPGATKVTFTVSDANGVKDVDADRSLNPQQTPGIWLHQGDPAISYQGPAPAPAPNTAILHYRRPAGDYTGWGLHLWDGAATPTADWGAPLLPESFDSFGAVFRIPLAAGATGLSYIMHAGEAKDLPTDQRLEFADAGREVWVQAGVQERLLPSVVKPAKLDLTRADAVRVDRDTIAWQTGTPDTLEPAGAATDGRVYDLVHAPNGGLRLVDGDLAGDYRSIRLTAQRDGLTEKQRRQAPELWQYPAFQAAAALPSGDGQFYVTERDAQGRLMSVTGVR	MRKLASIILFLAAVSNSLGQSKNSPLQISHLTGDFYVYRTFNDYKGTKISANAMYVVTDKGVVLFDAPWDKTQFQPLLDSIKAKHNKEVVMLFGTHSHEDRAGGFDFYKKKGIKTYSIKLTDDILKKNKEPRAEFIISNDTTFTVGNHTFEVYYPGKGHAPDNIVAWFKKEKILYGGCFVKSAEALDLGYLGDADVKEWQKSIKKVQAKFKKPDYIISGHDDWTSKESLNHTLKLVDEYLAQKSAGKK	418.55	gnl|BL_ORD_ID|297|hsp_num:0	222			381	483	
BGC0000691.1|Acarbose_14 # 16639 # 16791 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.601	BGC0000691.1|Acarbose_14 	16639	16791	+	Loose	500	21.1718	CTX-M-152	52.17	3002009	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	GTGGCGGTGATGCATCCATCACTGTATGCGCATCTGAATGACGTCTTCTGCAAGTTCTTGCAGCGGTCTCCGGGCCCTGCCCTTCCTCGTCATCCCTTCACAAGGAGAAGCTCGTGCAACGTCACGCCAGGCATGCCATCGCCGCGGCGGTAG	MAVMHPSLYAHLNDVFCKFLQRSPGPALPRHPFTRRSSCNVTPGMPSPRR	MRKSVRRAILMTTACVSLLLASVPLYAHANDVQQKLAALEKSSGGRLGVALINTADNTQTLYRADERFAMCSTSKVMAAAAVLKQSETQKDLLSQRVEIKSSDLINYNPIAEKHVNGTMTLGELSAAALQYSDNTAMNKLIAHLGGPGKVTAFARAIGDDTFRLDRTEPTLNTAIPGDPRDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGSGDYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY	17.24	gnl|BL_ORD_ID|1477|hsp_num:0	1616			72	141	
BGC0000691.1|Acarbose_18 # 20983 # 21153 # -1 # ID=1_18;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.596	BGC0000691.1|Acarbose_18 	20983	21153	-	Loose	450	23.483	cphA2	44.0	3003099	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	GAGATCGGCAAATGCAAGAGCGTCTCGCAGTTCATGGACCGCGACACCGTGCCCGACATGGCCAACGCGATGATCAAGCTGATCCAGCAGTTCATCGACCAGCCGACCCCGGAGACGATCGCGACCGTTCAGAAGAGCGCTGAGGACCAGGCGAAGACGATTTTCCGCTGA	EIGKCKSVSQFMDRDTVPDMANAMIKLIQQFIDQPTPETIATVQKSAEDQAKTIFR	MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPRTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEALIKAAPQS	22.05	gnl|BL_ORD_ID|1310|hsp_num:0	1428			207	282	
